Orbimed Advisors as of March 31, 2017
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 131 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alexion Pharmaceuticals | 5.2 | $456M | 3.8M | 121.24 | |
| Biogen Idec (BIIB) | 4.5 | $393M | 1.4M | 273.42 | |
| Celgene Corporation | 4.4 | $390M | 3.1M | 124.43 | |
| Boston Scientific Corporation (BSX) | 4.3 | $381M | 15M | 24.87 | |
| Merck & Co (MRK) | 4.1 | $363M | 5.7M | 63.54 | |
| Wright Medical Group Nv | 3.2 | $286M | 9.2M | 31.12 | |
| Eli Lilly & Co. (LLY) | 3.2 | $280M | 3.3M | 84.11 | |
| Incyte Corporation (INCY) | 3.0 | $264M | 2.0M | 133.67 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.7 | $237M | 2.2M | 109.35 | |
| Amgen (AMGN) | 2.7 | $236M | 1.4M | 164.07 | |
| Agilent Technologies Inc C ommon (A) | 2.2 | $192M | 3.6M | 52.87 | |
| Pfizer (PFE) | 2.1 | $185M | 5.4M | 34.21 | |
| Edwards Lifesciences (EW) | 2.0 | $173M | 1.8M | 94.07 | |
| Aetna | 1.9 | $167M | 1.3M | 127.55 | |
| Shire | 1.8 | $156M | 898k | 174.23 | |
| Hca Holdings (HCA) | 1.8 | $155M | 1.7M | 88.99 | |
| Humana (HUM) | 1.7 | $153M | 742k | 206.14 | |
| Regeneron Pharmaceuticals (REGN) | 1.7 | $147M | 378k | 387.51 | |
| Anthem (ELV) | 1.6 | $143M | 863k | 165.38 | |
| Abbvie (ABBV) | 1.5 | $136M | 2.1M | 65.16 | |
| Array BioPharma | 1.4 | $127M | 14M | 8.94 | |
| Ironwood Pharmaceuticals (IRWD) | 1.4 | $124M | 7.2M | 17.06 | |
| Bristol Myers Squibb (BMY) | 1.4 | $120M | 2.2M | 54.38 | |
| Centene Corporation (CNC) | 1.3 | $118M | 1.7M | 71.26 | |
| Intercept Pharmaceuticals In | 1.3 | $117M | 1.0M | 113.10 | |
| Allergan | 1.3 | $114M | 477k | 238.92 | |
| BioMarin Pharmaceutical (BMRN) | 1.3 | $112M | 1.3M | 87.78 | |
| Corvus Pharmaceuticals (CRVS) | 1.3 | $112M | 5.4M | 20.77 | |
| Johnson & Johnson (JNJ) | 1.2 | $110M | 885k | 124.55 | |
| Synergy Pharmaceuticals | 1.1 | $99M | 21M | 4.66 | |
| Tenet Healthcare Corporation (THC) | 1.1 | $95M | 5.4M | 17.71 | |
| Glaukos (GKOS) | 1.0 | $89M | 1.7M | 51.30 | |
| Insmed (INSM) | 0.9 | $84M | 4.8M | 17.51 | |
| Puma Biotechnology (PBYI) | 0.9 | $84M | 2.2M | 37.20 | |
| Thermo Fisher Scientific (TMO) | 0.9 | $82M | 534k | 153.60 | |
| Audentes Therapeutics | 0.9 | $82M | 4.8M | 17.04 | |
| Viewray (VRAYQ) | 0.9 | $81M | 9.5M | 8.51 | |
| Ascendis Pharma A S (ASND) | 0.9 | $76M | 2.7M | 28.00 | |
| Magellan Health Services | 0.8 | $75M | 1.1M | 69.05 | |
| Allergan Plc pfd conv ser a | 0.8 | $75M | 88k | 848.44 | |
| Loxo Oncology | 0.8 | $73M | 1.7M | 42.08 | |
| Aerie Pharmaceuticals | 0.8 | $68M | 1.5M | 45.35 | |
| Mallinckrodt Pub | 0.7 | $66M | 1.5M | 44.57 | |
| Insys Therapeutics | 0.7 | $64M | 6.1M | 10.51 | |
| Medtronic (MDT) | 0.7 | $62M | 767k | 80.56 | |
| Gw Pharmaceuticals Plc ads | 0.7 | $58M | 476k | 120.94 | |
| Achillion Pharmaceuticals | 0.6 | $55M | 13M | 4.21 | |
| Eagle Pharmaceuticals (EGRX) | 0.6 | $56M | 671k | 82.94 | |
| Gilead Sciences (GILD) | 0.6 | $54M | 801k | 67.92 | |
| Illumina (ILMN) | 0.6 | $55M | 322k | 170.64 | |
| Jazz Pharmaceuticals (JAZZ) | 0.6 | $54M | 371k | 145.13 | |
| Newlink Genetics Corporation | 0.6 | $53M | 2.2M | 24.10 | |
| Mylan Nv | 0.6 | $51M | 1.3M | 38.99 | |
| UnitedHealth (UNH) | 0.6 | $49M | 296k | 164.01 | |
| Immunomedics Inc note 4.750% 2/1 | 0.5 | $42M | 30M | 1.41 | |
| Stryker Corporation (SYK) | 0.5 | $42M | 316k | 131.65 | |
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $40M | 1.2M | 34.38 | |
| Global Blood Therapeutics In | 0.5 | $40M | 1.1M | 36.85 | |
| Intuitive Surgical (ISRG) | 0.4 | $39M | 50k | 766.47 | |
| Cooper Companies | 0.4 | $38M | 191k | 199.89 | |
| Intellia Therapeutics (NTLA) | 0.4 | $38M | 2.7M | 14.09 | |
| Dermira | 0.4 | $35M | 1.0M | 34.11 | |
| Beigene | 0.4 | $33M | 904k | 36.61 | |
| Assembly Biosciences | 0.4 | $32M | 1.3M | 25.49 | |
| Sarepta Therapeutics (SRPT) | 0.3 | $31M | 1.1M | 29.60 | |
| Momenta Pharmaceuticals | 0.3 | $28M | 2.1M | 13.35 | |
| Select Medical Holdings Corporation (SEM) | 0.3 | $28M | 2.1M | 13.35 | |
| Radius Health | 0.3 | $27M | 704k | 38.65 | |
| Obseva Sa | 0.3 | $27M | 2.6M | 10.41 | |
| Selecta Biosciences | 0.3 | $26M | 1.8M | 14.32 | |
| Bluebird Bio (BLUE) | 0.3 | $26M | 284k | 90.90 | |
| Lion Biotechnologies | 0.3 | $25M | 3.4M | 7.45 | |
| Galapagos Nv- (GLPG) | 0.3 | $24M | 284k | 86.19 | |
| ImmunoGen | 0.3 | $24M | 6.1M | 3.87 | |
| Otonomy | 0.3 | $23M | 1.9M | 12.25 | |
| Coherus Biosciences (CHRS) | 0.3 | $23M | 1.1M | 21.15 | |
| eHealth (EHTH) | 0.2 | $22M | 1.8M | 12.04 | |
| Xencor (XNCR) | 0.2 | $20M | 840k | 23.92 | |
| Nabriva Therapeutics | 0.2 | $20M | 1.7M | 12.00 | |
| Neurocrine Biosciences (NBIX) | 0.2 | $19M | 441k | 43.30 | |
| Pieris Pharmaceuticals | 0.2 | $19M | 7.3M | 2.60 | |
| Dbv Technologies S A | 0.2 | $18M | 513k | 35.22 | |
| Steadymed | 0.2 | $18M | 3.1M | 5.80 | |
| Sinovac Biotech | 0.2 | $15M | 2.7M | 5.73 | |
| C.R. Bard | 0.2 | $14M | 58k | 248.53 | |
| EXACT Sciences Corporation (EXAS) | 0.2 | $14M | 603k | 23.62 | |
| Teva Pharmaceutical Industries (TEVA) | 0.1 | $13M | 413k | 32.09 | |
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $13M | 1.8M | 7.34 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $12M | 15M | 0.82 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $12M | 2.3M | 5.00 | |
| Natera (NTRA) | 0.1 | $11M | 1.3M | 8.87 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $11M | 3.3M | 3.23 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $11M | 1.9M | 5.51 | |
| Wright Medical Group Rtsn V | 0.1 | $11M | 6.9M | 1.53 | |
| Aeglea Biotherapeutics | 0.1 | $11M | 1.5M | 7.45 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $9.9M | 1.7M | 5.69 | |
| Heron Therapeutics (HRTX) | 0.1 | $9.8M | 650k | 15.00 | |
| Dimension Therapeutics | 0.1 | $9.4M | 5.4M | 1.75 | |
| NuVasive | 0.1 | $9.2M | 124k | 74.68 | |
| Alkermes (ALKS) | 0.1 | $8.5M | 145k | 58.50 | |
| Cellectis S A (CLLS) | 0.1 | $8.4M | 350k | 24.00 | |
| Immunomedics | 0.1 | $8.0M | 1.2M | 6.47 | |
| Crispr Therapeutics (CRSP) | 0.1 | $8.1M | 372k | 21.77 | |
| Tesaro | 0.1 | $7.3M | 47k | 153.88 | |
| Fluidigm Corporation convertible cor | 0.1 | $6.8M | 10M | 0.68 | |
| Nevro (NVRO) | 0.1 | $7.3M | 78k | 93.70 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $6.7M | 485k | 13.72 | |
| Zimmer Holdings (ZBH) | 0.1 | $6.0M | 49k | 122.10 | |
| Redhill Biopharma Ltd cmn | 0.1 | $5.4M | 565k | 9.59 | |
| Minerva Neurosciences | 0.1 | $5.7M | 704k | 8.10 | |
| Invitae (NVTAQ) | 0.1 | $5.1M | 457k | 11.06 | |
| Sierra Oncology | 0.1 | $5.7M | 3.7M | 1.53 | |
| Alnylam Pharmaceuticals (ALNY) | 0.1 | $4.2M | 82k | 51.25 | |
| Affimed Therapeutics B V | 0.1 | $4.6M | 2.0M | 2.30 | |
| Sientra | 0.1 | $4.4M | 522k | 8.42 | |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.1 | $4.4M | 7.0M | 0.63 | |
| Roka Bioscience | 0.0 | $3.2M | 894k | 3.56 | |
| Xenon Pharmaceuticals (XENE) | 0.0 | $2.5M | 635k | 4.00 | |
| Clearside Biomedical (CLSD) | 0.0 | $2.4M | 300k | 7.94 | |
| Orexigen Therapeutics Inc note 2.750%12/0 | 0.0 | $2.6M | 5.2M | 0.50 | |
| Valeant Pharmaceuticals Int | 0.0 | $2.1M | 195k | 11.03 | |
| Vanda Pharmaceuticals (VNDA) | 0.0 | $703k | 50k | 14.00 | |
| Amarin Corporation (AMRN) | 0.0 | $1.1M | 350k | 3.20 | |
| Biolinerx Ltd-spons | 0.0 | $997k | 1.0M | 0.96 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $565k | 500k | 1.13 | |
| Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $595k | 500k | 1.19 | |
| Marinus Pharmaceuticals | 0.0 | $1.0M | 568k | 1.77 | |
| Noveliontherapeuti.. | 0.0 | $1.1M | 100k | 10.74 | |
| Alimera Sciences | 0.0 | $350k | 250k | 1.40 | |
| Xtant Med Holdings | 0.0 | $295k | 475k | 0.62 | |
| Medigus Ltd sponsord | 0.0 | $185k | 60k | 3.08 |
